Intra-Cellular Therapies (ITCI) Revenue US GAAP (year values) |
||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
Revenue, bln rub | ? | 0.061 | 22.5 | 81.7 | 249.1 | 462.2 | 512.3 | |
Changes by years, y/y, % | +37 071% | +263% | +205% | +86% |
Intra-Cellular Therapies. Revenue US GAAP, bln rub
Intra-Cellular Therapies. Revenue US GAAP, changes, %
Intra-Cellular Therapies. Revenue US GAAP, sum by quarters, bln rub
Intra-Cellular Therapies (ITCI) Revenue US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
Revenue, bln rub | ? | 94.7 | 110.1 | 125.8 | 131.5 | 144.9 | 512.3 | |
Changes by years, y/y, % | +173% | +100% | +75% | +50% | +53% | |||
Changes by quarters, q/q, % | +8% | +16% | +14% | +5% | +10% |